Rigel Securities Suit Tossed On Specificity Grounds
A federal judge has dismissed a securities class action against Rigel Pharmaceuticals Inc., finding that the plaintiffs had not proved the company knowingly omitted adverse results from tests on an experimental...To view the full article, register now.
Already a subscriber? Click here to view full article